Diabetes Care, Vol 20, Issue 11 1702-1705, Copyright © 1997 by American Diabetes Association
Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation
D Kumar and HJ Marshall
Department of Medicine, Los Angeles County University of Southern California Medical Center 90033, USA.
OBJECTIVE: To evaluate the efficacy of transcutaneous electrotherapy for
chronic painful peripheral neuropathy in patients with type 2 diabetes.
RESEARCH DESIGN AND METHODS: Thirty-one patients with symptoms and signs of
peripheral neuropathy were randomized to the electrotherapy or sham
treatment (control) group. The electrostimulation was given by a portable
unit (H-Wave machine) than generated a biphasic, exponentially decaying
waveform (pulse width 4 ms, 25-35 V, > or = 2 Hz). Patients treated each
of their lower extremities for 30 min daily for 4 weeks at home. Nine
patients from the sham-treatment group participated for a second period,
during which all of them received the active electrotherapy. Patient's
degree of pain and discomfort was graded on a scale of 0 to 5. RESULTS: In
the sham-treated group (n = 13), the neuropathic symptoms improved in five
(38%) patients, and the pain score declined from 2.92 +/- 0.13 to 2.38 +/-
0.26 (P < 0.04), suggesting a procedure-related placebo effect. In the
electrotherapy group (n = 18), symptomatic improvement was seen in 15 (83%)
cases, 3 of which were completely asymptomatic; the pain score declined
from 3.17 +/- 0.12 to 1.44 +/- 0.25 (P < 0.01) and the posttreatment
pain scores were considerably lower (P < 0.03), indicating a substantial
treatment effect over and above any placebo influence. Patients in the
electrotherapy group reported greater reduction in symptoms (52 +/- 7% vs.
27 +/- 10% in control subjects, P < 0.05) on an analog scale. Moreover,
the electrotherapy decreased pain scores (from 3.0 +/- 0.62 to 1.56 +/-
0.32, P < 0.02) in nine patients who had received sham treatment
earlier. CONCLUSIONS: A form of transcutaneous electrotherapy ameliorated
the pain and discomfort associated with peripheral neuropathy. This novel
modality offers a potential non-pharmacological treatment option.